Literature DB >> 27342859

A viral kinase mimics S6 kinase to enhance cell proliferation.

Aadra Prashant Bhatt1, Jason P Wong1, Marc S Weinberg2, Kurtis M Host1, Louise C Giffin1, Joshua Buijnink3, Evert van Dijk3, Yoshihiro Izumiya4, Hsing-Jien Kung5, Brenda R S Temple6, Blossom Damania7.   

Abstract

Viruses depend upon the host cell for manufacturing components of progeny virions. To mitigate the inextricable dependence on host cell protein synthesis, viruses can modulate protein synthesis through a variety of mechanisms. We report that the viral protein kinase (vPK) encoded by open reading frame 36 (ORF36) of Kaposi's sarcoma-associated herpesvirus (KSHV) enhances protein synthesis by mimicking the function of the cellular protein S6 kinase (S6KB1). Similar to S6KB1, vPK phosphorylates the ribosomal S6 protein and up-regulates global protein synthesis. vPK also augments cellular proliferation and anchorage-independent growth. Furthermore, we report that both vPK and S6KB1 phosphorylate the enzyme 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 (PFKFB2) and that both kinases promote endothelial capillary tubule formation.

Entities:  

Keywords:  KSHV; ORF36; S6K; cell signaling; viral protein kinase

Mesh:

Substances:

Year:  2016        PMID: 27342859      PMCID: PMC4948314          DOI: 10.1073/pnas.1600587113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

2.  ORF36 protein kinase of Kaposi's sarcoma herpesvirus activates the c-Jun N-terminal kinase signaling pathway.

Authors:  M Sabry Hamza; Richard A Reyes; Yoshihiro Izumiya; Ronald Wisdom; Hsing-Jien Kung; Paul A Luciw
Journal:  J Biol Chem       Date:  2004-07-05       Impact factor: 5.157

3.  Role of PFKFB3-driven glycolysis in vessel sprouting.

Authors:  Katrien De Bock; Maria Georgiadou; Sandra Schoors; Anna Kuchnio; Brian W Wong; Anna Rita Cantelmo; Annelies Quaegebeur; Bart Ghesquière; Sandra Cauwenberghs; Guy Eelen; Li-Kun Phng; Inge Betz; Bieke Tembuyser; Katleen Brepoels; Jonathan Welti; Ilse Geudens; Inmaculada Segura; Bert Cruys; Franscesco Bifari; Ilaria Decimo; Raquel Blanco; Sabine Wyns; Jeroen Vangindertael; Susana Rocha; Russel T Collins; Sebastian Munck; Dirk Daelemans; Hiromi Imamura; Roland Devlieger; Mark Rider; Paul P Van Veldhoven; Frans Schuit; Ramon Bartrons; Johan Hofkens; Peter Fraisl; Sucheta Telang; Ralph J Deberardinis; Luc Schoonjans; Stefan Vinckier; Jason Chesney; Holger Gerhardt; Mieke Dewerchin; Peter Carmeliet
Journal:  Cell       Date:  2013-08-01       Impact factor: 41.582

4.  Targeting of mTORC2 prevents cell migration and promotes apoptosis in breast cancer.

Authors:  Haiyan Li; Jun Lin; Xiaokai Wang; Guangyu Yao; Liping Wang; Hang Zheng; Cuilan Yang; Chunhong Jia; Anling Liu; Xiaochun Bai
Journal:  Breast Cancer Res Treat       Date:  2012-04-04       Impact factor: 4.872

5.  The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity.

Authors:  David Shahbazian; Philippe P Roux; Virginie Mieulet; Michael S Cohen; Brian Raught; Jack Taunton; John W B Hershey; John Blenis; Mario Pende; Nahum Sonenberg
Journal:  EMBO J       Date:  2006-06-08       Impact factor: 11.598

6.  Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma.

Authors:  Aadra P Bhatt; Sarah R Jacobs; Alex J Freemerman; Liza Makowski; Jeffrey C Rathmell; Dirk P Dittmer; Blossom Damania
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-29       Impact factor: 11.205

7.  Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling.

Authors:  Sang-Hoon Sin; Debasmita Roy; Ling Wang; Michelle R Staudt; Farnaz D Fakhari; Dhavalkumar D Patel; David Henry; William J Harrington; Blossom A Damania; Dirk P Dittmer
Journal:  Blood       Date:  2006-11-02       Impact factor: 22.113

8.  Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells.

Authors:  Ling Wang; Blossom Damania
Journal:  Cancer Res       Date:  2008-06-15       Impact factor: 12.701

Review 9.  Functions and regulation of the 70kDa ribosomal S6 kinases.

Authors:  Tim R Fenton; Ivan T Gout
Journal:  Int J Biochem Cell Biol       Date:  2010-10-12       Impact factor: 5.085

10.  Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function.

Authors:  Adam J Hume; Jonathan S Finkel; Jeremy P Kamil; Donald M Coen; Michael R Culbertson; Robert F Kalejta
Journal:  Science       Date:  2008-05-09       Impact factor: 47.728

View more
  19 in total

1.  Human herpesvirus-encoded kinase induces B cell lymphomas in vivo.

Authors:  Penny M Anders; Nathan D Montgomery; Stephanie A Montgomery; Aadra P Bhatt; Dirk P Dittmer; Blossom Damania
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

2.  Lysosome Membrane Permeabilization and Disruption of the Molecular Target of Rapamycin (mTOR)-Lysosome Interaction Are Associated with the Inhibition of Lung Cancer Cell Proliferation by a Chloroquinoline Analog.

Authors:  Juan Sironi; Evelyn Aranda; Lars Ulrik Nordstrøm; Edward L Schwartz
Journal:  Mol Pharmacol       Date:  2018-11-08       Impact factor: 4.436

Review 3.  Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.

Authors:  Dirk P Dittmer; Blossom Damania
Journal:  J Clin Invest       Date:  2016-09-01       Impact factor: 14.808

Review 4.  Modulation of oncogenic signaling networks by Kaposi's sarcoma-associated herpesvirus.

Authors:  Jason P Wong; Blossom Damania
Journal:  Biol Chem       Date:  2017-07-26       Impact factor: 3.915

5.  Conserved Herpesvirus Kinase ORF36 Activates B2 Retrotransposons during Murine Gammaherpesvirus Infection.

Authors:  Aaron M Schaller; Jessica Tucker; Ian Willis; Britt A Glaunsinger
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103

6.  Kaposi sarcoma-associated herpesvirus miRNAs suppress CASTOR1-mediated mTORC1 inhibition to promote tumorigenesis.

Authors:  Tingting Li; Enguo Ju; Shou-Jiang Gao
Journal:  J Clin Invest       Date:  2019-07-15       Impact factor: 14.808

Review 7.  In Vivo Models of Oncoproteins Encoded by Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Ariana G Bravo Cruz; Blossom Damania
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

8.  Regulation of Mumps Virus Replication and Transcription by Kinase RPS6KB1.

Authors:  Kelsey Briggs; Leyi Wang; Kaito Nagashima; James Zengel; Ralph A Tripp; Biao He
Journal:  J Virol       Date:  2020-06-01       Impact factor: 5.103

Review 9.  Kaposi sarcoma.

Authors:  Ethel Cesarman; Blossom Damania; Susan E Krown; Jeffrey Martin; Mark Bower; Denise Whitby
Journal:  Nat Rev Dis Primers       Date:  2019-01-31       Impact factor: 52.329

10.  Combined Inhibition of Akt and mTOR Is Effective Against Non-Hodgkin Lymphomas.

Authors:  Ricardo Rivera-Soto; Yi Yu; Dirk P Dittmer; Blossom Damania
Journal:  Front Oncol       Date:  2021-06-18       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.